HOME >> BIOLOGY >> NEWS
Study: Adults maintain significant improvement in ADHD with long-term use of amphetamine

CHAPEL HILL -- Adults with attention-deficit-hyperactivity disorder treated long term with an extended-release mixed-salts amphetamine medication maintained significant symptom improvement with good tolerance, a new study shows.

University of North Carolina at Chapel Hill researchers presented the study results - from one of the largest trials ever conducted of adult ADHD - today (May 21) at the American Psychiatric Association annual meeting, the world's largest psychiatric conference.

"ADHD is not just a childhood disorder. While hyperactivity may sometimes diminish by adulthood, inattention and impulsivity often remain," said Dr. Richard H. Weisler, adjunct professor of psychiatry at UNC's School of Medicine.

"Our findings suggest that, as in children with ADHD, adults who have this condition can benefit from treatment with this product. This medication can significantly improve adults' ADHD symptoms and, subsequently, their ability to work, socialize and be more productive in everyday activities."

Weisler also is adjunct assistant professor of psychiatry and behavioral sciences at Duke University Medical Center and has a private practice in Raleigh.

Analysis of a four-week, multi-center, phase III pivotal acute double-blind trial data of 248 patients indicated a once-daily extended-release mixed-salts amphetamine medication to be effective and well-tolerated for treating adults with ADHD, Weisler said.

This medication controlled ADHD symptoms up to 12 hours after a single morning dose. The 20-milligram daily dose was determined to be the minimum effective dose for adults with ADHD; for some patients, effectiveness improved as the dose was increased. Improvement in symptom management was maintained throughout the four-week study.

At the end of the trial, the average ADHD Rating Scale (or ADHD-RS) Total Scores, the primary measure of effectiveness, were significantly lower for each medication dose trea
'"/>

Contact: Deb Saine
deborah_saine@unc.edu
919-962-8415
University of North Carolina at Chapel Hill
21-May-2003


Page: 1 2 3 4

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study: A little help from friends makes wounds heal faster
3. Study: Mothers turn fearless when peptide level drops
4. Study: Artificial sweetener may disrupt bodys ability to count calories
5. Study: Mimicking viruses may provide new way to defeat them
6. Study: Stroke victims may retain continuous motion ability
7. Study: Prenatal screening in Haiti region cut syphilis by 75 percent
8. Study: Isoflavone-enriched soy proteins fail to increase bone mineral density in young women
9. Study: Genome-wide scanning unravels complex birth defect
10. Study: Higher energy intake, obesity affects all age groups, not just youths
11. Study: Showering boosts concentrations of potentially hazardous trihalomethanes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2017)... Solutions, a global clinical research organization (CRO), announces the launch of ... 4, 2017. Shadow is designed to assist medical writers and biometrics ... the European Medicines Agency (EMA) in meeting the requirements for de-identifying ... ... ...
(Date:7/20/2017)... DAL ) customers now can use fingerprints instead of their ... (DCA). ... launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in May at ... process to allow eligible Delta SkyMiles Members who are enrolled in CLEAR ...
(Date:6/14/2017)... 15, 2017  IBM (NYSE: IBM ) is introducing several ... dedicated to developing collaboration between startups and global businesses, taking ... During the event, nine startups will showcase the solutions they ... industries. France is ... with a 30 percent increase in the number of startups ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
Breaking Biology Technology:
Cached News: